{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:08:37Z","timestamp":1793196517181,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.cgh.2006.09.012","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T07:27:38Z","timestamp":1166167658000},"page":"178-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Effects of Proton-Pump Inhibitors on Functional Dyspepsia: A Meta-analysis of Randomized Placebo-Controlled Trials"],"prefix":"10.1016","volume":"5","author":[{"given":"Wei Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge Fan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry H.X.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Guang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Karlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.cgh.2006.09.012_bib1","first-page":"ii37","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley","year":"1999","journal-title":"Gut"},{"issue":"Suppl 4","key":"10.1016\/j.cgh.2006.09.012_bib2","first-page":"iv10","article-title":"Clinical and economic consequences of dyspepsia in the community","volume":"50","author":"Moayyedi","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02064375","article-title":"Impact of functional dyspepsia on quality of life","volume":"40","author":"Talley","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2006.09.012_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/003655202762671260","article-title":"Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial","volume":"37","author":"Bolling-Sternevald","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.47.4.473","article-title":"Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status","volume":"47","author":"Blum","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004836-199806000-00022","article-title":"Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia","volume":"26","author":"Finney","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1080\/003655201750305440","article-title":"Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies","volume":"36","author":"Allescher","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib9","article-title":"Pharmacological interventions for non-ulcer dyspepsia","volume":"2","author":"Soo","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2006.09.012_bib10","series-title":"Technology report no. 22. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)","article-title":"The efficacy of proton pump inhibitors in adults with functional dyspepsia","author":"Shiau","year":"2002"},{"key":"10.1016\/j.cgh.2006.09.012_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.51.4.502","article-title":"Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients","volume":"51","author":"Wong","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","article-title":"Dyspepsia and dyspepsia subgroups: a population-based study","volume":"102","author":"Talley","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.09.012_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/pgmj.70.821.154","article-title":"Prevalence of dyspepsia: the epidemiology of overlapping symptoms","volume":"70","author":"Grainger","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2006.09.012_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001960","article-title":"Pharmacological interventions for non-ulcer dyspepsia","volume":"1","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2006.09.012_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.09.012_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/003655299750026029","article-title":"Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern","volume":"34","author":"Farup","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.dld.2004.09.021","article-title":"A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia","volume":"37","author":"Gerson","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2006.09.012_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2006.09.012_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2006.09.012_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjmed.2004.01.008","article-title":"Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials","volume":"116","author":"Peura","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2006.09.012_bib21","first-page":"A89","article-title":"Therapeutic efficacy of 15 mg lansoprazole mane in 269 patients suffering from non-ulcer dyspepsia (NUD): a multicentre, randomized, double-blind study","volume":"43","author":"Hengels","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.1998.00423.x","article-title":"Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis","volume":"12","author":"Laheij","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib23","first-page":"619","article-title":"A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome","volume":"51","author":"Lewin-van-den-Broek","year":"2001","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cgh.2006.09.012_bib24","first-page":"2777","article-title":"Which dyspepsia patients will benefit from omeprazole treatment?","volume":"95","author":"Meineche-Schmidt","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib25","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/j.1572-0241.2002.07123.x","article-title":"A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia","volume":"97","author":"Rabeneck","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.09.012_bib26","doi-asserted-by":"crossref","first-page":"A730","DOI":"10.1016\/S0016-5085(08)83637-2","article-title":"The symptom relieving effect of omeprazole 40 mg daily is not significantly better than 20 mg in patients with acid related disease from general practice","volume":"120","author":"Meineche-Schmidt","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.09.012_bib27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2004.02243.x","article-title":"Classification of dyspepsia and response to treatment with proton-pump inhibitors","volume":"20","author":"Meineche-Schmidt","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1572-0241.2004.30089.x","article-title":"Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption","volume":"99","author":"Meineche-Schmidt","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1572-0241.2005.40280.x","article-title":"A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study","volume":"100","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1046\/j.1365-2036.2000.00866.x","article-title":"Identifying responders to acid suppression in dyspepsia using a random starting day trial","volume":"14","author":"Bytzer","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2036.1998.0284f.x","article-title":"First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid\/alginate liquid: a multicentre study in general practice","volume":"12","author":"Goves","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2036.1999.00455.x","article-title":"Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia","volume":"13","author":"Jones","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1997.00179.x","article-title":"Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice","volume":"11","author":"Jones","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2036.1998.00282.x","article-title":"The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate\/ranitidine management strategy","volume":"12","author":"Mason","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2036.2004.02072.x","article-title":"Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design","volume":"20","author":"Madsen","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2036.2004.02084.x","article-title":"Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial\u2014is gastro-oesophageal reflux important?","volume":"20","author":"Madsen","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/003655299750026010","article-title":"Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment","volume":"34","author":"Meineche-Schmidt","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib38","series-title":"An acid suppression trial with esomeprazole identifies patients with non-ulcer dyspepsia who will respond to prolonged acid suppression: a randomized controlled trial of 1589 endoscoped patients","author":"Talley","year":"2005"},{"key":"10.1016\/j.cgh.2006.09.012_bib39","first-page":"365","article-title":"Which patients with ulcer- or reflux-like dyspepsia will respond favorably to omeprazole?","volume":"50","author":"Singh","year":"2001","journal-title":"J Fam Pract"},{"issue":"Suppl 4","key":"10.1016\/j.cgh.2006.09.012_bib40","first-page":"iv36","article-title":"The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies","volume":"50","author":"Talley","year":"2002","journal-title":"Gut"},{"issue":"Suppl 4","key":"10.1016\/j.cgh.2006.09.012_bib41","first-page":"A702","article-title":"Effect of omeprazole in functional dyspepsia: a double-blind, randomized, placebo-controlled study","volume":"110","author":"Lauritsen","year":"1996","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2006.09.012_bib42","doi-asserted-by":"crossref","first-page":"A439","DOI":"10.1016\/S0016-5085(00)83870-6","article-title":"Low-dose lansoprazole: effective for non-ulcer dyspepsia (NUD)","volume":"118","author":"Peura","year":"2000","journal-title":"Gastroenterology"},{"issue":"suppl 3","key":"10.1016\/j.cgh.2006.09.012_bib43","first-page":"A1873","article-title":"Low-dose lansoprazole: effective for non-ulcer dyspepsia (NUD)","volume":"49","author":"Pilmer","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2036.2003.01651.x","article-title":"Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?","volume":"18","author":"Bolling-Sternevald","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1440-1746.2000.02148.x","article-title":"Gastro-oesophageal reflux disease in Asia","volume":"15","author":"Goh","year":"2000","journal-title":"J Gastroenterol Hapatol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.09.012_bib46","first-page":"S13","article-title":"Non-erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both?","volume":"13","author":"Quigley","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.09.012_bib47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2036.2003.01423.x","article-title":"Non-erosive reflux disease (NERD)\u2014acid reflux and symptom patterns","volume":"17","author":"Mantinez","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib48","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archinte.160.12.1803","article-title":"Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease","volume":"160","author":"Richter","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2006.09.012_bib49","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"4","author":"van","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2006.09.012_bib50","first-page":"2849","article-title":"Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease","volume":"96","author":"Armstrong","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/gut.36.2.189","article-title":"Importance of reflux symptoms in functional dyspepsia","volume":"36","author":"Small","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","article-title":"Therapy for Helicobacter pylori in patients with nonulcer dyspepsia","volume":"134","author":"Laine","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2006.09.012_bib53","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia","volume":"1","author":"Moayyedi","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2006.09.012_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.2004.01878.x","article-title":"Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia","volume":"19","author":"Abraham","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib55","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.36.4.534","article-title":"A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients","volume":"36","author":"El-Omar","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.09.012_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2036.2004.01751.x","article-title":"Dyspeptic symptoms associated with Helicobacter pylori infection are influenced by strain and host specific factors","volume":"19","author":"Treiber","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.09.012_bib57","series-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.4.","article-title":"Analysing and presenting results","author":"Deeks","year":"2005"},{"key":"10.1016\/j.cgh.2006.09.012_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Meta-analysis bias in location and selection of studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2006.09.012_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.316.7126.221","article-title":"Meta-analysis: unresolved issues and future developments","volume":"316","author":"Davey Smith","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2006.09.012_bib60","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trials methodology with recommendations for design of future trials","volume":"91","author":"Veldhuyzen van Zanten","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.09.012_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/003655200750024065","article-title":"The impact of dyspepsia definition on prevalence estimates: considerations for future researchers","volume":"35","author":"Westbrook","year":"2000","journal-title":"Scand J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506009402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506009402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:10Z","timestamp":1761541150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356506009402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1542356506009402"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.09.012","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Proton-Pump Inhibitors on Functional Dyspepsia: A Meta-analysis of Randomized Placebo-Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2006.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2006.12.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}